These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2566488)

  • 1. Biphasic effect of D-2 agonist quinpirole on locomotion and movements.
    Eilam D; Szechtman H
    Eur J Pharmacol; 1989 Feb; 161(2-3):151-7. PubMed ID: 2566488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intracerebral quinpirole on locomotion in rats.
    Van Hartesveldt C; Cottrell GA; Potter T; Meyer ME
    Eur J Pharmacol; 1992 Apr; 214(1):27-32. PubMed ID: 1582450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion.
    Mogenson GJ; Wu M
    Brain Res; 1991 Jun; 551(1-2):216-20. PubMed ID: 1680523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole.
    Eilam D; Szechtman H
    Pharmacol Biochem Behav; 1990 Aug; 36(4):989-91. PubMed ID: 1977180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine.
    Moody CA; Frambes NA; Spear LP
    Psychopharmacology (Berl); 1992; 108(3):256-62. PubMed ID: 1355920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats.
    Frantz KJ; Van Hartesveldt C
    Psychopharmacology (Berl); 1995 Jun; 119(3):299-304. PubMed ID: 7675965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements.
    Eilam D; Golani I; Szechtman H
    Brain Res; 1989 Jun; 490(2):255-67. PubMed ID: 2527582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of dopamine D2 agonist quinpirole upon the dorsal immobility response in rats.
    Meyer ME; Meyer ME; Potter TJ; Van Hartesveldt C
    Pharmacol Biochem Behav; 1992 Jun; 42(2):257-9. PubMed ID: 1352900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinpirole alters quadruped activity in rats from the second postnatal week.
    Eilam D; Szechtman H; Spear LP
    Dev Psychobiol; 1992 May; 25(4):275-89. PubMed ID: 1352505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinpirole to the accumbens reduces exploratory and amphetamine-elicited locomotion.
    Mogenson GJ; Wu M
    Brain Res Bull; 1991 Nov; 27(5):743-6. PubMed ID: 1684529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole.
    Sullivan R; Dogaru C; Szechtman H
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1217-9. PubMed ID: 1361993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogenetic quinpirole treatment induces vertical jumping activity in rats.
    Kostrzewa RM; Guo J; Kostrzewa FP
    Eur J Pharmacol; 1993 Aug; 239(1-3):183-7. PubMed ID: 7901028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Fernández M
    Eur J Pharmacol; 1989 Oct; 169(1):61-6. PubMed ID: 2574689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats.
    Kostrzewa RM; Brus R; Kalbfleisch J
    Eur J Pharmacol; 1991 Dec; 209(3):157-61. PubMed ID: 1686767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-amphetamine injected into the nucleus accumbens on ethanol reinforced behavior.
    Samson HH; Tolliver GA; Haraguchi M; Kalivas PW
    Brain Res Bull; 1991 Aug; 27(2):267-71. PubMed ID: 1683808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration.
    Doty RL; Risser JM
    Psychopharmacology (Berl); 1989; 98(3):310-5. PubMed ID: 2568654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats.
    Koshikawa N; Koshikawa F; Tomiyama K; Kikuchi de Beltrán K; Kamimura F; Kobayashi M
    Eur J Pharmacol; 1990 Jul; 182(2):375-80. PubMed ID: 1975784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity.
    Steketee JD; Kalivas PW
    J Pharmacol Exp Ther; 1992 May; 261(2):811-8. PubMed ID: 1349649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.